(PAYX) Paychex - Ratings and Ratios
Payroll, Tax, Benefits, HR, Insurance
PAYX EPS (Earnings per Share)
PAYX Revenue
Description: PAYX Paychex September 29, 2025
Paychex Inc. (NASDAQ: PAYX) delivers a suite of human-capital-management (HCM) solutions-including payroll processing, tax administration, employee benefits, HR support, and insurance services-to small- and medium-sized enterprises across the United States, Europe, and India. Its core offering spans end-to-end payroll calculation, check issuance, tax filing, and remittance, complemented by compliance assistance and reporting tools.
Beyond payroll, the firm provides retirement-plan administration, talent-acquisition platforms, workforce-management tools, and a digital marketplace for earned-wage and financial-wellness products. Paychex also offers risk-management outsourcing and on-site or virtual HR representatives, positioning itself as a one-stop provider for non-payroll HR needs. Sales are primarily driven by a direct sales force that targets the fragmented SMB segment.
Key performance indicators as of FY 2024 show revenue of $5.0 billion, a 6 % year-over-year growth rate, and an adjusted EBITDA margin of roughly 22 %, reflecting strong pricing power in a market where U.S. small-business payroll spending is projected to expand at 4-5 % annually (source: IBISWorld). The sector’s growth is further fueled by rising gig-economy participation and tighter regulatory scrutiny on payroll tax compliance, both of which increase demand for automated, compliant solutions.
For a deeper quantitative comparison of PAYX’s valuation metrics, you might explore the analysis on ValueRay.
PAYX Stock Overview
| Market Cap in USD | 44,990m |
| Sub-Industry | Human Resource & Employment Services |
| IPO / Inception | 1990-03-26 |
PAYX Stock Ratings
| Growth Rating | 11.9% |
| Fundamental | 86.3% |
| Dividend Rating | 78.0% |
| Return 12m vs S&P 500 | -28.9% |
| Analyst Rating | 2.83 of 5 |
PAYX Dividends
| Dividend Yield 12m | 4.44% |
| Yield on Cost 5y | 7.12% |
| Annual Growth 5y | 11.48% |
| Payout Consistency | 98.1% |
| Payout Ratio | 83.7% |
PAYX Growth Ratios
| Growth Correlation 3m | -92.4% |
| Growth Correlation 12m | -29% |
| Growth Correlation 5y | 84.7% |
| CAGR 5y | 4.00% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.15 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.63 |
| Sharpe Ratio 12m | -0.54 |
| Alpha | -32.58 |
| Beta | 0.913 |
| Volatility | 30.13% |
| Current Volume | 2754.2k |
| Average Volume 20d | 2476.2k |
| Stop Loss | 113.5 (-3%) |
| Signal | -0.01 |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (1.61b TTM) > 0 and > 6% of Revenue (6% = 347.6m TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA -3.91pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 32.99% (prev 37.99%; Δ -5.00pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 2.13b > Net Income 1.61b (YES >=105%, WARN >=100%) |
| Net Debt (4.21b) to EBITDA (2.56b) ratio: 1.65 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.27 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (361.9m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 72.83% (prev 71.77%; Δ 1.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 42.67% (prev 50.63%; Δ -7.96pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 13.90 (EBITDA TTM 2.56b / Interest Expense TTM 164.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.46
| (A) 0.11 = (Total Current Assets 9.04b - Total Current Liabilities 7.13b) / Total Assets 16.66b |
| (B) 0.12 = Retained Earnings (Balance) 2.07b / Total Assets 16.66b |
| (C) 0.17 = EBIT TTM 2.28b / Avg Total Assets 13.58b |
| (D) 0.16 = Book Value of Equity 2.05b / Total Liabilities 12.69b |
| Total Rating: 2.46 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 86.26
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield 3.98% = 1.99 |
| 3. FCF Margin 33.19% = 7.50 |
| 4. Debt/Equity 1.26 = 1.75 |
| 5. Debt/Ebitda 1.65 = 0.69 |
| 6. ROIC - WACC (= 16.85)% = 12.50 |
| 7. RoE 39.99% = 2.50 |
| 8. Rev. Trend 73.45% = 5.51 |
| 9. EPS Trend 46.46% = 2.32 |
What is the price of PAYX shares?
Over the past week, the price has changed by -6.08%, over one month by -7.68%, over three months by -18.91% and over the past year by -13.63%.
Is Paychex a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PAYX is around 103.22 USD . This means that PAYX is currently overvalued and has a potential downside of -11.8%.
Is PAYX a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 13
- Sell: 3
- Strong Sell: 1
What are the forecasts/targets for the PAYX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 135 | 15.4% |
| Analysts Target Price | 135 | 15.4% |
| ValueRay Target Price | 115.1 | -1.6% |
PAYX Fundamental Data Overview October 29, 2025
P/E Trailing = 27.904
P/E Forward = 22.779
P/S = 7.7661
P/B = 11.1868
P/EG = 2.3742
Beta = 0.913
Revenue TTM = 5.79b USD
EBIT TTM = 2.28b USD
EBITDA TTM = 2.56b USD
Long Term Debt = 4.55b USD (from longTermDebt, last quarter)
Short Term Debt = 418.4m USD (from shortTermDebt, last quarter)
Debt = 5.02b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.21b USD (from netDebt column, last quarter)
Enterprise Value = 48.34b USD (44.99b + Debt 5.02b - CCE 1.67b)
Interest Coverage Ratio = 13.90 (Ebit TTM 2.28b / Interest Expense TTM 164.0m)
FCF Yield = 3.98% (FCF TTM 1.92b / Enterprise Value 48.34b)
FCF Margin = 33.19% (FCF TTM 1.92b / Revenue TTM 5.79b)
Net Margin = 27.86% (Net Income TTM 1.61b / Revenue TTM 5.79b)
Gross Margin = 72.83% ((Revenue TTM 5.79b - Cost of Revenue TTM 1.57b) / Revenue TTM)
Gross Margin QoQ = 73.13% (prev 72.40%)
Tobins Q-Ratio = 2.90 (Enterprise Value 48.34b / Total Assets 16.66b)
Interest Expense / Debt = 1.36% (Interest Expense 68.2m / Debt 5.02b)
Taxrate = 22.85% (113.7m / 497.5m)
NOPAT = 1.76b (EBIT 2.28b * (1 - 22.85%))
Current Ratio = 1.27 (Total Current Assets 9.04b / Total Current Liabilities 7.13b)
Debt / Equity = 1.26 (Debt 5.02b / totalStockholderEquity, last quarter 3.97b)
Debt / EBITDA = 1.65 (Net Debt 4.21b / EBITDA 2.56b)
Debt / FCF = 2.19 (Net Debt 4.21b / FCF TTM 1.92b)
Total Stockholder Equity = 4.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.68% (Net Income 1.61b / Total Assets 16.66b)
RoE = 39.99% (Net Income TTM 1.61b / Total Stockholder Equity 4.04b)
RoCE = 26.56% (EBIT 2.28b / Capital Employed (Equity 4.04b + L.T.Debt 4.55b))
RoIC = 25.39% (NOPAT 1.76b / Invested Capital 6.93b)
WACC = 8.54% (E(44.99b)/V(50.01b) * Re(9.38%) + D(5.02b)/V(50.01b) * Rd(1.36%) * (1-Tc(0.23)))
Discount Rate = 9.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.03%
[DCF Debug] Terminal Value 75.18% ; FCFE base≈1.80b ; Y1≈1.99b ; Y5≈2.59b
Fair Price DCF = 98.59 (DCF Value 35.48b / Shares Outstanding 359.9m; 5y FCF grow 12.21% → 3.0% )
EPS Correlation: 46.46 | EPS CAGR: 7.89% | SUE: 1.93 | # QB: 1
Revenue Correlation: 73.45 | Revenue CAGR: 9.82% | SUE: 0.00 | # QB: 0
Additional Sources for PAYX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle